NECTIN4 and neoplasm: Among 27 available matched primary and metastatic samples, the NECTIN4 copy number variation was stable in 93% of samples, with 7 of 8 NECTIN4-amplified primary tumor tissue samples retaining the amplification in the matched metastatic sample.